A. O. Smith (AOS) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
19 Jan, 2026Executive summary
Q3 2024 sales declined 4% year-over-year to $903M, mainly due to lower China and North America water heater demand, while India sales grew 12% and North America boiler and water treatment businesses delivered double-digit growth.
Net earnings for Q3 were $120.1M, down from $135.4M last year; diluted EPS declined 9% to $0.82.
Dividend increased by 6% to $0.34/share, marking 32 consecutive years of annual increases.
Pureit acquisition from Unilever for $120M is on track to close by year-end, expected to double India business and enhance South Asia presence.
Acquisitions in water treatment added $6M in Q3 and $14M in nine months to net sales.
Financial highlights
Q3 2024 net earnings were $120.1M, down from $135.4M in Q3 2023; adjusted EPS was $0.82, compared to $0.90 last year.
North America segment Q3 sales were $703M, down 1% year-over-year; segment earnings fell to $162.5M with a margin of 23.1%.
Rest of World Q3 sales dropped 10% to $210M; China sales declined 17% in local currency, India sales up 12%.
Free cash flow for the first nine months was $282.5M, down from $396.3M in 2023, due to higher inventories and incentive payments.
Cash balance at quarter-end was $256M; net cash position $136M; leverage ratio 5.9%.
Outlook and guidance
2024 consolidated sales expected to be flat year-over-year, in the range of $3.8–$3.9B; guidance excludes future acquisitions.
Full-year EPS guidance reaffirmed at $3.70–$3.85.
China sales guidance lowered to a 6–8% decrease in local currency; North American boiler and water treatment sales to grow 8–10%.
U.S. residential and commercial water heater industry volumes projected to be flat; boiler sales growth guidance revised to ~8%.
Free cash flow guidance reduced to $415M; CapEx for 2024 projected at $105–$115M, up due to expansion projects.
Latest events from A. O. Smith
- Proxy details director elections, executive pay, auditor ratification, and enhanced ESG oversight.AOS
Proxy Filing4 Mar 2026 - Record EPS, margin expansion, and strategic M&A drive 2026 growth outlook.AOS
Q4 20253 Feb 2026 - Q2 sales up 7% to $1.02B, EPS up 5%, 2024 guidance reaffirmed, Pureit deal to close by year-end.AOS
Q2 20243 Feb 2026 - 2024 sales and earnings dipped, but 2025 targets margin gains and strong shareholder returns.AOS
Q4 20249 Jan 2026 - Q1 2025 sales fell 2% year-over-year, but 2025 guidance and margin gains remain solid.AOS
Q1 202525 Dec 2025 - Proxy covers director elections, executive pay, auditor ratification, and ESG-linked incentives.AOS
Proxy Filing1 Dec 2025 - Director nominee Adrian I. Peace withdrew; Board reduced to nine, proxy cards remain valid.AOS
Proxy Filing1 Dec 2025 - Q2 2025 EPS rose to $1.07 as margins improved and 2025 guidance was raised.AOS
Q2 20255 Nov 2025 - Q3 2025 sales up 4%, EPS up 15%, North America strong, China down 12%, 2025 EPS $3.70–$3.85.AOS
Q3 202529 Oct 2025